These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23647074)

  • 1. HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women.
    Kirschner B; Schledermann D; Holl K; Rosenlund M; Raillard A; Quint W; Molijn A; Jenkins D; Junge J
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1032-40. PubMed ID: 23647074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV genotypes in invasive cervical cancer in Danish women.
    Kirschner B; Junge J; Holl K; Rosenlund M; Collas de Souza S; Quint W; Molijn A; Jenkins D; Schledermann D
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1023-31. PubMed ID: 23763577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
    Tjalma WA; Fiander A; Reich O; Powell N; Nowakowski AM; Kirschner B; Koiss R; O'Leary J; Joura EA; Rosenlund M; Colau B; Schledermann D; Kukk K; Damaskou V; Repanti M; Vladareanu R; Kolomiets L; Savicheva A; Shipitsyna E; Ordi J; Molijn A; Quint W; Raillard A; Rosillon D; De Souza SC; Jenkins D; Holl K;
    Int J Cancer; 2013 Feb; 132(4):854-67. PubMed ID: 22752992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J; Cox JT; Behrens C; Sandri M; Franco EL; Yap PS; Huh W
    Gynecol Oncol; 2015 Apr; 137(1):47-54. PubMed ID: 25667973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV genotype distribution according to severity of cervical neoplasia.
    Sjoeborg KD; Tropé A; Lie AK; Jonassen CM; Steinbakk M; Hansen M; Jacobsen MB; Cuschieri K; Eskild A
    Gynecol Oncol; 2010 Jul; 118(1):29-34. PubMed ID: 20406711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
    J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women.
    Chao A; Jao MS; Huang CC; Huang HJ; Cheng HH; Yang JE; Hsueh S; Chen TC; Qiu JT; Lin CT; Fu CJ; Chou HH; Lai CH
    Int J Cancer; 2011 Feb; 128(3):653-9. PubMed ID: 20473874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
    Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J; Zhang D; Yang Z; Wang X; Wang D
    BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
    Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
    J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.
    Thomsen LT; Frederiksen K; Munk C; Junge J; Iftner T; Kjaer SK
    Int J Cancer; 2015 Jul; 137(1):193-203. PubMed ID: 25471319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; van de Sandt MM; Lycke KD; de Koning MNC; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1227-1235. PubMed ID: 37469102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.